The China Food and Drug Administration has issued 90 industry standards – 14 mandatory and 76 recommended – covering implants for surgery, medical electrical equipment, in vitro diagnostic reagents and dentistry.
The standards will improve the medical device standards system of China, help improve the quality of medical devices and promote the sound development of medical device industry, the CFDA says in an announcement posted earlier this month.
The 14 mandatory standards will take effect Jan. 1, 2017, while the 76 recommended standards will take effect Jan. 1, 2016, says John Balzano, special counsel for Covington & Burling’s food and drug practice group.
The standards are part of the CFDA’s ongoing device regulatory reform, which aims to increase the quality of devices in the Chinese market, he tells IDDM.
Jack Wong, director of regulatory affairs for Asia Pacific in TerumoBCT’s Singapore branch, says it is difficult to describe the impact to industry, but recommends that companies identify any standards related to their products to determine whether they are in compliance.